Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02549131 · ClinicalTrials.gov registry record · NA
Cesarean Wound Closure in Women With BMI 40 or Greater
A NA study, sponsored by Pediatrix.
- Completed
- Registry status
- NA
- Development phase
- 232
- Enrollment target
NCT02549131: Completed NA study, sponsored by Pediatrix.
NCT02549131 is a NA study that has completed, run by Pediatrix. The registered enrollment target is 232 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02549131, a NA study, has completed, sponsored by Pediatrix.
- COMPLETED
- Registry status
- NA
- Development phase
- 232 participants
- Enrollment target
Study Summary
The purpose of this randomized controlled prospective trial is to guide physicians on the most effective evidenced based skin closure during a cesarean section for the obese gravida, defined as a BMI of 40 or greater. The study will compare two closure methods: subcuticular sutures and surgical staples.
Primary Outcome
Rate of wound complication comparing the outcomes of subcuticular sutures to surgical staples for cesarean wound closure in the obese gravida during the first 6 weeks postpartum.
Interventions
- PROCEDURE Randomizing to Suture or Staple closure of Cesarean section
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 232 participants |
| Start Date | 2015-09 |
| Est. Completion | 2021-01 |
| Phase | NA |
What the finished NCT02549131 record still lists
NCT02549131 is an interventional study that assigns participants to a tested intervention. The registered 232 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 1 intervention - of which Randomizing to Suture or Staple closure of Cesarean section is the first listed.
NCT02549131 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02549131 about?
NCT02549131 is a clinical study titled "Cesarean Wound Closure in Women With BMI 40 or Greater". The purpose of this randomized controlled prospective trial is to guide physicians on the most effective evidenced based skin closure during a cesarean section for the obese gravida, defined as a BMI of 40 or greater. The study will compare two closure methods: subcuticular sutures and surgical stap...
What is the current status of trial NCT02549131?
This trial is currently completed. It is a NA study. The enrollment target is 232 participants. The study started on 2015-09. Estimated completion is 2021-01.
What interventions are being tested in trial NCT02549131?
The interventions under investigation include: Randomizing to Suture or Staple closure of Cesarean section (PROCEDURE).
Who is sponsoring clinical trial NCT02549131?
This trial is sponsored by Pediatrix, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02549131's enrollment target sits among peer trials
232 463rd of 2000 higher than 1,536 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01356290 · 232 participants · Phase 2
Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors
- NCT04753359 · 232 participants · NA
Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer
- NCT04770870 · 232 participants · NA
Post Approval Study2: Hintermann Series H3 Total Ankle Replacement System
- NCT05948943 · 232 participants · Phase 2
Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia